APA način citiranja

Miglietta, F., Griguolo, G., Bottosso, M., Giarratano, T., Mele, M. L., Fassan, M., . . . Dieci, M. V. (2022). HER2-low-positive breast cancer: Evolution from primary tumor to residual disease after neoadjuvant treatment. Nature Portfolio.

Čikaški stil citiranja

Miglietta, Federica, et al. HER2-low-positive Breast Cancer: Evolution From Primary Tumor to Residual Disease After Neoadjuvant Treatment. Nature Portfolio, 2022.

MLA način citiranja

Miglietta, Federica, et al. HER2-low-positive Breast Cancer: Evolution From Primary Tumor to Residual Disease After Neoadjuvant Treatment. Nature Portfolio, 2022.